Abstract
The relationship between white matter injury (WMI) and mitochondrial dysfunction (either within neurons or glia) is emerging as a sophisticated synergistic interconnection that has only recently begun to be investigated. In a recent shift away from the traditional neurocentric view of the brain, the new Gestalt perspective of the CNS embraces the intercellular interactions between grey matter and white matter and their substantial dependence on mitochondria for survival. In addition, the variations in mitochondrial activity and dynamics between cell types may underlie inherent differences in vulnerability between glial and neural cells. Thus, the newer questions on the interplay between white matter, mitochondria, and neurons are themselves complex. First, what are the implications of mitochondrial dysfunction within white matter cells themselves, and second, what is the global impact of WMI on mitochondrial function within neuronal cells? To address these questions, the present review describes the nature of mitochondria in neurons and glia and examines their functional roles. We then explore the impact of WMI on mitochondria and neuronal fate. Finally, the possibility that white matter diseases are closely related to mitochondrial disorders is considered, with reference to the conspicuous overlap in their clinical presentations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abramov AY, Canevari L, Duchen MR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24(2):565–575
Amiri M, Hollenbeck PJ (2008) Mitochondrial biogenesis in the axons of vertebrate peripheral neurons. Dev Neurobiol 68(11):1348–1361
Andrews H, White K, Thomson C, Edgar J, Bates D, Griffiths I, Turnbull D, Nichols P (2006) Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J Neurosci Res 83(8):1533–1539
Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21(4):1302–1312
Back SA, Riddle A, McClure MM (2007) Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 38(2 suppl):724–730
Bambrick L, Kristian T, Fiskum G (2004) Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res 29(3):601–608
Bambrick LL, Chandrasekaran K, Mehrabian Z, Wright C, Krueger BK, Fiskum G (2006) Cyclosporin A increases mitochondrial calcium uptake capacity in cortical astrocytes but not cerebellar granule neurons. J Bioenerg Biomembr 38(1):43–47
Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871–927
Bhatti MT, Newman NJ (1999) A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 19(1):28–33
Boumezbeur F, Petersen KF, Cline GW, Mason GF, Behar KL, Shulman GI, Rothman DL (2010) The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy. J Neurosci 30(42):13983–13991
Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology. Acta Neuropathol 119(1):37–53
Brown AM, Wender R, Ransom BR (2001) Metabolic substrates other than glucose support axon function in central white matter. J Neurosci Res 66(5):839–843
Cambron M, D’Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J (2012) White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab 32(3):413–424
Campbell GR, Mahad DJ (2012) Mitochondrial changes associated with demyelination: consequences for axonal integrity. Mitochondrion 12(2):173–179
Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Leon A, Robinson KM, Mason RP, Beckman JS, Barbeito L, Radi R (2008) Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci 28(16):4115–4122
Chen Y, Swanson RA (2003) Astrocytes and brain injury. J Cereb Blood Flow Metab 23(2):137–149
DiNuzzo M, Mangia S, Maraviglia B, Giove F (2010) Glycogenolysis in astrocytes supports blood-borne glucose channeling not glycogen-derived lactate shuttling to neurons: evidence from mathematical modeling. J Cereb Blood Flow Metab 30(12):1895–1904
Dugan LL, Kim-Han JS (2004) Astrocyte mitochondria in in vitro models of ischemia. J Bioenerg Biomembr 36(4):317–321
Edgar JM, McCulloch MC, Thomson CE, Griffiths IR (2008) Distribution of mitochondria along small-diameter myelinated central nervous system axons. J Neurosci Res 86(10):2250–2257
Finsterer J, Hoftberger R, Stollberger C, Rolinski B (2012) Mimicry between mitochondrial disorder and multiple sclerosis. Metab Brain Dis 27(2):217–220
Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517–521
Gandhi GK, Cruz NF, Ball KK, Dienel GA (2009) Astrocytes are poised for lactate trafficking and release from activated brain and for supply of glucose to neurons. J Neurochem 111(2):522–536
Genc S, Kurnaz IA, Ozilgen M (2011) Astrocyte-neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions—in silico study supported by in vitro expression data. BMC Syst Biol 5:162
Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, McDonald WI, Compston DA (1992) Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain 115(pt 4):979–989
Harris JJ, Attwell D (2012) The energetics of CNS white matter. J Neurosci 32(1):356–371
Hochachka PW, Mommsen TP (1983) Protons and anaerobiosis. Science 219(4591):1391–1397
Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, LeDoux SP (2000) Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med 28(8):1161–1174
Hwang JM, Chang BL, Park SS (2001) Leber’s hereditary optic neuropathy mutations in Korean patients with multiple sclerosis. Ophthalmologica 215(6):398–400
Idestrup CP, Salter MW (1998) P2Y and P2U receptors differentially release intracellular Ca2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord. Neuroscience 86(3):913–923
Jolivet R, Allaman I, Pellerin L, Magistretti PJ, Weber B (2010) Comment on recent modeling studies of astrocyte-neuron metabolic interactions. J Cereb Blood Flow Metab 30(12):1982–1986
Kahraman S, Bambrick LL, Fiskum G (2011) Effects of FK506 and cyclosporin a on calcium ionophore-induced mitochondrial depolarization and cytosolic calcium in astrocytes and neurons. J Neurosci Res 89(12):1973–1978
Kann O, Kovacs R (2007) Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292(2):C641–C657
Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE (1994) Leber’s hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 36(1):109–112
Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276(7):4588–4596
Kovacs GG, Hoftberger R, Majtenyi K, Horvath R, Barsi P, Komoly S, Lassmann H, Budka H, Jakab G (2005) Neuropathology of white matter disease in Leber’s hereditary optic neuropathy. Brain 128(pt 1):35–41
Kristian T, Hopkins IB, McKenna MC, Fiskum G (2006) Isolation of mitochondria with high respiratory control from primary cultures of neurons and astrocytes using nitrogen cavitation. J Neurosci Methods 152(1–2):136–143
Krzeminski P, Misiewicz I, Pomorski P, Kasprzycka-Guttman T, Baranska J (2007) Mitochondrial localization of P2Y1, P2Y2 and P2Y12 receptors in rat astrocytes and glioma C6 cells. Brain Res Bull 71(6):587–592
Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA (2011) DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 196:251–264
Lax NZ, Campbell GR, Reeve AK, Ohno N, Zambonin J, Blakely EL, Taylor RW, Bonilla E, Tanji K, DiMauro S, Jaros E, Lassmann H, Turnbull DM, Mahad DJ (2012) Loss of myelin-associated glycoprotein in kearns-sayre syndrome. Arch Neurol 69(4):490–499
LeDoux SP, Druzhyna NM, Hollensworth SB, Harrison JF, Wilson GL (2007) Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults. Neuroscience 145(4):1249–1259
Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, ** L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487(7408):443–448
Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T (2002) White matter abnormalities in Leber’s hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 6(2):121–123
Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119(6):873–887
Mangia S, Giove F, Tkac I, Logothetis NK, Henry PG, Olman CA, Maraviglia B, Di Salle F, Ugurbil K (2009a) Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab 29(3):441–463
Mangia S, Simpson IA, Vannucci SJ, Carruthers A (2009b) The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J Neurochem 109(suppl 1):55–62
Mao P, Reddy PH (2010) Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta 1802(1):66–79
McCormack JG, Halestrap AP, Denton RM (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70(2):391–425
Morris RL, Hollenbeck PJ (1993) The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci 104(pt 3):917–927
Mullett SJ, Hinkle DA (2009) DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone. Neurobiol Dis 33(1):28–36
Mullett SJ, Di Maio R, Greenamyre JT, Hinkle DA (2013) DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress. J Mol Neurosci 49(3):507–511
Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T (1995) No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 45(7):1333–1334
Oliveira JM, Goncalves J (2009) In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum. J Biol Chem 284(8):5010–5020
Olsen NK, Hansen AW, Norby S, Edal AL, Jorgensen JR, Rosenberg T (1995) Leber’s hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol Scand 91(5):326–329
Ouyang YB, Lu Y, Yue S, Giffard RG (2012) miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 12(2):213–219
Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91(22):10625–10629
Pierre K, Pellerin L (2005) Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94(1):1–14
Swanson RA, Benington JH (1996) Astrocyte glucose metabolism under normal and pathological conditions in vitro. Dev Neurosci 18(5–6):515–521
Swanson RA, Choi DW (1993) Glial glycogen stores affect neuronal survival during glucose deprivation in vitro. J Cereb Blood Flow Metab 13(1):162–169
Swanson RA, Farrell K, Stein BA (1997) Astrocyte energetics, function, and death under conditions of incomplete ischemia: a mechanism of glial death in the penumbra. Glia 21(1):142–153
Talley Watts L, Sprague S, Zheng W, Garling RJ, Jimenez D, Digicaylioglu M, Lechleiter J (2013) Purinergic 2Y(1) receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model. J Neurotrauma 30(1):55–66
Tekkok SB, Brown AM, Westenbroek R, Pellerin L, Ransom BR (2005) Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Res 81(5):644–652
Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A 107(41):17757–17762
Voloboueva LA, Suh SW, Swanson RA, Giffard RG (2007) Inhibition of mitochondrial function in astrocytes: implications for neuroprotection. J Neurochem 102(4):1383–1394
Wu J, Holstein JD, Upadhyay G, Lin DT, Conway S, Muller E, Lechleiter JD (2007) Purinergic receptor-stimulated IP3-mediated Ca2+ release enhances neuroprotection by increasing astrocyte mitochondrial metabolism during aging. J Neurosci 27(24):6510–6520
Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9(4):453–457
Xu L, Emery JF, Ouyang YB, Voloboueva LA, Giffard RG (2010) Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia 58(9):1042–1049
Yoo BK, Choi JW, Yoon SY, Ko KH (2005) Protective effect of adenosine and purine nucleos(t)ides against the death by hydrogen peroxide and glucose deprivation in rat primary astrocytes. Neurosci Res 51(1):39–44
Young EA, Fowler CD, Kidd GJ, Chang A, Rudick R, Fisher E, Trapp BD (2008) Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions. Ann Neurol 63(4):428–435
Yu-Wai-Man P, Griffiths PG, Chinnery PF (2011) Mitochondrial optic neuropathies—disease mechanisms and therapeutic strategies. Prog Retin Eye Res 30(2):81–114
Zheng W, Watts LT, Holstein DM, Prajapati SI, Keller C, Grass EH, Walter CA, Lechleiter JD (2010) Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One 5(12):e14401
Zheng W, Talley Watts L, Holstein DM, Wewer J, Lechleiter JD (2013) P2Y(1)R-initiated, IP(3)R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse. J Cereb Blood Flow Metab 33(4):600–611
Zhu D, Lai Y, Shelat PB, Hu C, Sun GY, Lee JC (2006) Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci 26(43):11111–11119
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stetler, R.A. et al. (2014). The Interplay Between White Matter, Mitochondria, and Neuroprotection. In: Baltan, S., Carmichael, S., Matute, C., **, G., Zhang, J. (eds) White Matter Injury in Stroke and CNS Disease. Springer Series in Translational Stroke Research, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9123-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9123-1_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9122-4
Online ISBN: 978-1-4614-9123-1
eBook Packages: MedicineMedicine (R0)